Whatever your diagnosis, our expert network will help you identify your best personalized treatment options—quickly, clearly, and free of charge. ASK Cancer Commons now.

Whatever your diagnosis, our expert network will help you identify your best personalized treatment options—quickly, clearly, and free of charge. ASK Cancer Commons now.

Whatever your diagnosis, our expert network will help you identify your best options quickly, clearly, and free of charge. ASK Cancer Commons now.

Get decision support for the best
personalized treatment option

Reengineering Immune System
Cells to Fight Glioblastoma

In our latest Knowledge Blog post, chief scientist Emma Shtivelman covers new research into CAR T-cell therapy. Read now.

In our latest Knowledge Blog post, chief scientist Emma Shtivelman covers new research into CAR T-cell therapy. Read now.

In our latest Knowledge Blog post, chief scientist Emma Shtivelman covers new research into CAR T-cell therapy. Read now.

Dyanne ski

Our very own Masako Yokota shares her lung cancer experience.
Read her story.

Our very own Masako Yokota shares her lung cancer experience.
Read her story.

Our very own Masako Yokota shares her lung cancer experience.
Read her story.

"I just wanted to pay it forward"

Row of houses

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Founder and melanoma survivor Marty Tenenbaum is dedicated to helping every patient access the knowledge they need. Read Marty's story.

Born from
necessity

Arrow
Arrow
Slider

Changing the way the world treats cancer, starting with you.

Cancer Commons is a patient-centric not-for-profit network of patients, physicians, and scientists that help identify the best options for treating an individual’s cancer. Members contribute to and benefit from a uniquely dynamic knowledge base of case histories, treatment insights and rationales, clinical trials, and patient outcomes and experiences.

Each case builds on this collective knowledge, enabling more accurate personalized options for the next community member.  By learning from each and every patient in this way, we can optimize and expand the use of available treatments far more efficiently than clinical trials, and rapidly improve outcomes for patients with advanced cancer.